| related words |
| demonstrate |
| genetic |
| cancer |
| laboratory |
| protocol |
| advanced |
| marketed |
| eliminated |
| therapeutic |
| compound |
| efficacy |
| abbott |
| commercializing |
| vaccine |
| pharmacy |
| commercialized |
| therapy |
| tarceva |
| introduced |
| melafind |
|
| related documents |
| 1466593--2/26/2010--Otter_Tail_Corp |
| 1076481--3/16/2010--SEQUENOM_INC |
| 319240--3/14/2008--IRIS_INTERNATIONAL_INC |
| 1076481--3/30/2007--SEQUENOM_INC |
| 1076481--3/31/2006--SEQUENOM_INC |
| 319240--3/6/2009--IRIS_INTERNATIONAL_INC |
| 1063561--12/20/2010--PROSPECT_MEDICAL_HOLDINGS_INC |
| 859737--11/24/2010--HOLOGIC_INC |
| 1045829--8/26/2010--VANGUARD_HEALTH_SYSTEMS_INC |
| 899923--8/12/2010--MYRIAD_GENETICS_INC |
| 1145238--9/24/2010--INSIGHT_HEALTH_SERVICES_HOLDINGS_CORP |
| 1063665--9/23/2010--CORGENIX_MEDICAL_CORP/CO |
| 881890--6/14/2010--ABAXIS_INC |
| 1279695--3/16/2010--UNIVERSAL_BIOSENSORS_INC |
| 1403385--3/9/2010--Symetra_Financial_CORP |
| 353569--2/26/2010--QUIDEL_CORP_/DE/ |
| 1022079--2/17/2010--QUEST_DIAGNOSTICS_INC |
| 1105184--3/11/2010--NANOSPHERE_INC |
| 820237--2/25/2010--GEN_PROBE_INC |
| 1383183--3/18/2010--CombiMatrix_Corp |
|
| related topics |
| {product, candidate, development} |
| {regulation, government, change} |
| {product, liability, claim} |
| {product, market, service} |
| {property, intellectual, protect} |
| {financial, litigation, operation} |
| {operation, natural, condition} |
| {system, service, information} |
| {cost, operation, labor} |
| {customer, product, revenue} |
| {tax, income, asset} |
| {debt, indebtedness, cash} |
| {stock, price, operating} |
| {operation, international, foreign} |
| {personnel, key, retain} |
| {stock, price, share} |
| {condition, economic, financial} |
| {cost, regulation, environmental} |
| {gas, price, oil} |
| {control, financial, internal} |
|